Medicare’s Drug-Pricing Proposal Carries A Hidden Cost
“CMS’s proposal would encourage one thing above all else: investing less in improving existing medicines,” says health expert…
WHO Guidance, GLP-1 Price Curbs Unlikely to Change Practice
A new World Health Organization (WHO) guideline recommending GLP-1s for obesity treatment along with recent efforts to reduce…